CTVA

$80.05

Market ClosedAs of Mar 17, 8:02 PM UTC

Corteva, Inc.

Intraday

Custom Range:
to
No data available for this range. Intraday data may be limited by the exchange.

Recent News

Zacks
Mar 17, 2026

Avocado Supply Surge: How Mission Produce Capitalizes on Peru

AVO leverages Peru's avocado supply surge with a volume-driven model, boosting efficiency, asset use and global sourcing to drive sustainable growth.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barrons.com
Mar 12, 2026

Deere, Caterpillar and 10 Other Stocks for an AI-Infused Blue Collar Renaissance

Artificial intelligence is the angel and demon fueling most stock trades these days, whether boosting companies tied to hyperscalers’ hyperspending on AI data centers or tanking software companies’ shares on fears of permanent irrelevance. “Justifiable attention has been paid to [AI’s] impact on the white-collar workforce,” wrote Oppenheimer analysts led by Colin Rusch in a Thursday report. “As such, we see a multi-year supportive backdrop across our Industrial Innovation coverage universe where we see the picks and shovels of this next wave of the Industrial Revolution; physical AI, power, and the machines that make the machines that power, build, and feed the world,” added Rusch.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Barchart
Mar 10, 2026

Is Corteva Stock Underperforming the Nasdaq?

While Corteva has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 10, 2026

Is Corteva (CTVA) Fairly Priced After Strong Multi‑Year Share Price Gains

If you have been wondering whether Corteva's current share price lines up with its underlying worth, you are not alone. This article is built to help you assess that question clearly. Corteva's share price recently closed at US$78.30, with returns of 7.9% over the last 30 days, 15.6% year to date, 31.3% over 1 year, 38.1% over 3 years and 76.6% over 5 years. This may signal that the market's view of its risk and opportunity has shifted over time. Recent coverage around Corteva has focused on...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Mar 10, 2026

Corteva Biofungicide Push And Business Split Reshape Long Term Story

Corteva (NYSE:CTVA) is partnering with Ascribe Bio to develop seed-applied biofungicide technology aimed at more targeted disease control in crops. The company has also announced an upcoming Investor Day, where it plans to outline the separation of its seed genetics and crop protection businesses. These moves highlight Corteva's focus on reshaping its portfolio and product pipeline in agricultural inputs. Corteva, trading at $78.3, sits in a stronger spot than a year ago, with the share...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.